Llwytho...
Design and Inference for 3-Stage Bioequivalence Testing with Serial Sampling Data
A bioequivalence test is to compare bioavailability parameters, such as the maximum observed concentration (C(max)) or the area under the concentration-time curve (AUC), for a test drug and a reference drug. During the planning of a bioequivalence test, it requires an assumption about the variance o...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharm Stat |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6146059/ https://ncbi.nlm.nih.gov/pubmed/29726096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1865 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|